FIL Ltd Q4 2025 13F: Canadian Banks and Mega-Cap Tech Share the Book

Marcus Chen

FIL Ltd's Q4 2025 13F shows $133.60B in reported value, led by MSFT and a diversified institutional tail.

Why This Q4 Filing Is Worth Reading

FIL Ltd reported $133.60B of 13F assets for 2025Q4, with 500 displayed positions in the current holdings view and a WhaleScore of 70.50. This is not a single-stock manifesto. It is a scaled institutional filing, so the useful signal is the shape of exposure: which names dominate the dollars, how much of the portfolio sits in the first screen, and whether the same market factors show up across comparable filers.

The largest displayed holding was MSFT at $4.28B, equal to 3.26% of disclosed value. The top five represented about 13.3% of the portfolio, while the top ten represented about 21.7%. That is enough concentration to matter, but still broad enough that investors should read the filing as a diversified institutional book rather than a narrow hedge-fund bet.

FIL Ltd Top Holdings — 2025Q4 ($M)

Loading Chart...

The Top-Holdings Map

The top holdings show how heavily the current institutional market still leans on mega-cap technology, platform software, semiconductors, and large financial or consumer franchises. In this run, the generated fact pack does not provide a reliable prior-quarter position-change table, so this article treats the filing as a Q4 snapshot rather than claiming that each top row was a fresh purchase.

TickerValueWeightShares
MSFT$4.28B3.26%8.85M
RY$3.97B3.02%23.26M
GOOGL$3.39B2.58%10.84M
SHOP$2.96B2.25%18.39M
TD$2.92B2.22%30.98M
AMZN$2.83B2.16%12.28M
AAPL$2.70B2.05%9.91M
AEM$2.18B1.66%12.88M

That caveat is important. A 13F snapshot can tell you where reported value sits today; it cannot, without a clean comparable baseline, prove intent. The current book still gives investors a useful risk map. A reader can compare NVDA, MSFT, AAPL, AMZN, and AVGO exposure across FIL Ltd, Schroder, Nordea, and Qube Research to see whether the same names are becoming crowded institutional defaults.

FIL Ltd Top 5 vs Rest Concentration — 2025Q4

Loading Chart...

Concentration, Not Just Size

The top-five-versus-rest chart keeps the interpretation grounded. FIL Ltd's first five displayed holdings made up roughly 13.3% of the filing, leaving about 86.7% in the remaining tail. That means the biggest names can still drive reported returns, but the book is not simply a one-stock or one-sector vehicle.

For retail investors, that distinction changes how the data should be used. Copying only the top few positions can create a much more concentrated portfolio than the filer actually reported. A better use is to identify which exposures are common across large institutions and then ask what catalyst could challenge the shared thesis.

FIL Ltd AUM History

Loading Chart...

The AUM Trend

The history table adds context to the current report. Recent values moved through 2025Q1 at $105.25B, 2025Q2 at $117.10B, 2025Q3 at $127.26B, 2025Q4 at $133.60B. Those moves can reflect price performance, reporting scope, amendments, and actual allocation changes. They should not be read as pure inflow or outflow without supporting evidence.

QuarterReported 13F ValueHoldings
2024Q1$100.86B1508
2024Q2$101.14B1516
2024Q3$110.32B1619
2024Q4$107.04B1588
2025Q1$105.25B1593
2025Q2$117.10B1601
2025Q3$127.26B1672
2025Q4$133.60B1705

The Investor Takeaway

FIL Ltd's Q4 2025 filing is most useful as a market-structure signal. It shows where a scaled institutional holder had its largest disclosed U.S.-listed equity exposure at quarter-end. The strongest takeaway is not that every top position is a new conviction buy; it is that mega-cap technology and related platform exposure remain the common language of large institutional portfolios.

Used correctly, this filing can help investors compare crowding, concentration, and portfolio breadth. Used incorrectly, it can tempt investors to clone a few large rows and miss the diversification, mandate, and reporting context that made the original filing look the way it did.

Explore all research